Track topics on Twitter Track topics that are important to you
RATIONALE: Collecting and storing tissue samples from patients with melanocytic nevi or pigmented lesions to study in the laboratory may help doctors learn more about the development of melanoma.
PURPOSE: This clinical trial is collecting and storing tissue samples to study in the laboratory from patients with melanocytic nevi or pigmented lesions.
- Obtain tissue from benign melanocytic nevi and LCMN for experimental study.
- Refine culture and immortalization methods for melanocytes derived from melanocytic nevi that permits in vitro expansion of these cells for functional study.
- Correlate clinical and dermoscopic observations of primary melanoma with histopathology to establish standards for sampling primary melanoma in a possible future study.
- Obtain, prospectively, a set of tissue samples of melanocytic nevi and primary melanoma with detailed clinical information for evaluating novel diagnostic techniques and for the basis of a nevus/primary melanoma tissue microarray.
OUTLINE: Patients are stratified according to diagnosis (children ≤ 5 years of age with large congenital melanocytic nevi vs adults with ≥ 100 acquired melanocytic nevi vs adults with suspected primary melanoma).
Patients undergo extensive full-body photography to document the number, type, and location of melanocytic nevi and pigmented lesions. Patients will also undergo excisional or staged (incisional and excisional) biopsy* of the melanocytic nevi or pigmented lesions. Dermoscopic images are performed before and after biopsy* on both clinically benign melanocytic nevi and pigmented lesions that are clinically suspicious for primary melanoma. Patients with a diagnosis of malignant melanoma receive standard care for primary melanoma.
NOTE: *Patients with lesions < 4 mm OR lesions 4-6 mm with ≤ 1-axis symmetry do not undergo biopsy.
Biopsy tissue will be used for immortalization of nevus-derived melanocytes and mutation screening (e.g., somatic mutations at codon 599 of BRAF and codon 61 of NRAS) and functional studies (e.g., gene expression analysis) of nevus-derived melanocytes.
Patients diagnosed with malignant melanoma and < 100 acquired melanocytic nevi are followed every 6 months for ≥ 2 years and then annually for ≥ 3 years. All other patients are followed every 6 months.
PROJECTED ACCRUAL: A total of 110 patients will be accrued for this study.
gene expression analysis, mutation analysis, biologic sample preservation procedure, biopsy, diagnostic imaging technique
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
National Cancer Institute (NCI)
Published on BioPortfolio: 2014-08-27T03:44:14-0400
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to c...
RATIONALE: Using samples of blood, urine, sputum, and tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and...
RATIONALE: The identification of gene mutations in young patients with pleuropulmonary blastoma syndrome may allow doctors to better understand the genetic processes involved in the develo...
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to fatigue. ...
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers relate...
The reliability of differential gene expression analysis on formalin-fixed, paraffin-embedded (FFPE) expression profiles generated using Affymetrix arrays is questionable, due to the high range of per...
Research synthesis, e.g. by meta-analysis, is more and more considered in the area of high-dimensional data from molecular research such as gene and protein expression data, especially because most st...
To study the clinical phenotype and gene mutation analysis of a hereditary abnormal fibrinogenemia family and explore its molecular pathogenesis.
To make a gene diagnosis for a family with Ectodysplasin A (EDA) gene mutation as well as prenatal diagnosis, and report a novel EDA gene mutation.
Gene expression changes over the lifespan and varies among different tissues or cell types. Gene co-expression also changes by sex, age, different tissues or cell types. However, gene expression under...
The analysis of a chemical substance by inserting a sample into a carrier stream of reagent using a sample injection valve that propels the sample downstream where mixing occurs in a coiled tube, then passes into a flow-through detector and a recorder or other data handling device.
Hybridization of a nucleic acid sample to a very large set of oligonucleotide probes, which are attached to a solid support, to determine sequence or to detect variations in a gene sequence or expression or for gene mapping.
MOLECULAR BIOLOGY techniques used in the diagnosis of disease. Included are such techniques as IN SITU HYBRIDIZATION of chromosomes for CYTOGENETIC ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS of gene expression patterns in disease states; identification of pathogenic organisms by analysis of species specific DNA sequences; and detection of mutations with POLYMERASE CHAIN REACTION.
Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction.
Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....